Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
SpringWorks Therapeutics, Inc. | General Counsel & Secretary | Common Stock | 52.2K | $2.17M | $41.53 | Jan 8, 2024 | Direct |
SpringWorks Therapeutics, Inc. | General Counsel & Secretary | Stock Option (Right to Buy) | 60K | Jan 4, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SWTX | SpringWorks Therapeutics, Inc. | Jan 4, 2024 | 4 | -$189K | 4 | Jan 8, 2024 | General Counsel & Secretary |
SWTX | SpringWorks Therapeutics, Inc. | Jan 7, 2023 | 1 | -$24K | 4 | Jan 10, 2023 | General Counsel & Secretary |
SWTX | SpringWorks Therapeutics, Inc. | Jan 5, 2023 | 4 | -$49K | 4 | Jan 9, 2023 | General Counsel & Secretary |
SWTX | SpringWorks Therapeutics, Inc. | Jan 7, 2022 | 1 | -$54.2K | 4/A | Jan 14, 2022 | General Counsel & Secretary |
SWTX | SpringWorks Therapeutics, Inc. | Jan 6, 2022 | 2 | $0 | 4 | Jan 10, 2022 | General Counsel & Secretary |